SCHEMBL21597017

SCHEMBL21597017

CCCCOC(=O)N1CC[C@H](OS(=O)(=O)c2ccc(C)cc2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.50
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 1/20 0.44
GPR119 Q8TDV5 2/20 0.44
KMT2A Q03164 1/20 0.44
CHRM2 P08172 1/20 0.44
CHRM1 P11229 1/20 0.44
TP53 P04637 1/20 0.43
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MMP3 P08254 2/20 0.43
MMP9 P14780 2/20 0.43
MMP13 P45452 2/20 0.43
MMP2 P08253 1/20 0.43
MMP8 P22894 1/20 0.43
CYP1A2 P05177 1/20 0.43
MMP1 P03956 1/20 0.42
MMP7 P09237 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18173570 0.94 CYP2D6 (0.46) CYP2D6ALDH1A1KDM4EGPR119KMT2A
SCHEMBL16245059 0.93 CYP2D6 (0.55) CYP2D6ALDH1A1KDM4EGPR119KMT2A
SCHEMBL29426713 0.84 ALDH1A1 (0.46) CYP2D6ALDH1A1KDM4EGPR119KMT2A
SCHEMBL25199281 0.84 ALDH1A1 (0.46) ALDH1A1KDM4EKMT2ACHRM2CHRM1
SCHEMBL9852971 0.84 CYP2D6 (0.62) CYP2D6ALDH1A1KDM4EKMT2ATP53
SCHEMBL20595140 0.83 CYP2D6 (0.57) CYP2D6ALDH1A1KDM4EKMT2AMAPK1
SCHEMBL30003332 0.83 CYP2D6 (0.42) CYP2D6ALDH1A1KDM4EGPR119KMT2A
SCHEMBL3789109 0.82 SMN1; SMN2 (0.51) CYP2D6MMP3MMP9MMP13MMP2
SCHEMBL3615713 0.82 SMN1; SMN2 (0.51) CYP2D6MMP3MMP9MMP13MMP2
SCHEMBL8788495 0.82 SMN1; SMN2 (0.51) CYP2D6MMP3MMP9MMP13MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3810594-A1 OGA INHIBITOR COMPOUNDS Janssen Pharmaceutica NV (BE) 2021-04-28 EP disclosed
WO-2019243527-A1 OGA INHIBITOR COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2019-12-26 WO disclosed